drugset / Trial / NCT03692286

Assessment of Postoperative Pain After Using Various Intracanal Medication in Patients With Necrotic Pulp

NCT03692286

Phase 4 Completed 30 enrolled Cairo University
RandomizedParallel-groupTriple-blindTreatment

Summary

To assess the Postoperative Pain after using Silver Nanoparticles with and without Calcium Hydroxide as an Intracanal Medication in Patients with necrotic pulp (RCT)

Timeline

Start
2019-06-01
Primary completion
2020-08-18
Completion
2020-09-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Calcium Hydroxide Other / unclassified Other
Comparator Silver nanoparticles Unknown Other

Indications

No indication recorded.